Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model
Described are three-dimensional, engineered, biological breast tissues, adipose tissues, and tumor models, including breast cancer models.
1. A three-dimensional, engineered, biological tumor model comprising:
a. stromal tissue; and
b. tumor tissue;
the tumor tissue comprising cancer cells, the tumor tissue in contact with the stromal tissue to form the three-dimensional, engineered, biological tumor model, wherein the tumor model does not comprise a perfusable vascular network, does not comprise red blood cells, and lacks innervation and neural tissue;
provided that the stromal tissue was bioprinted from a stromal bio-ink comprising human preadipocytes exposed to an adipocyte differentiation media for preadipocytes, and the tumor tissue was bioprinted from a tumor bio-ink.
2. The tumor model of claim 1 , wherein the tumor tissue is surrounded on three or more sides by the stromal tissue to form the three-dimensional, engineered, biological tumor model.
3. The tumor model of claim 2 , wherein the tumor tissue is completely surrounded on all sides by the stromal tissue to form the three-dimensional, engineered, biological tumor model.
4. The tumor model of claim 1 , wherein the model is substantially free of pre-formed scaffold.
5. The tumor model of claim 1 , wherein the stromal tissue comprises:
a. endothelial cells
b. fibroblasts, and
c. adipocytes or preadipocytes or both adipocytes and preadipocytes.
6. The tumor model of claim 1 , wherein the tumor tissue further comprises one or more of: endothelial cells, fibroblasts, adipocytes, and preadipocytes.
7. The tumor model of claim 1 , wherein the tumor model is a human breast cancer model, the stromal tissue is human breast stroma comprising human mammary fibroblasts, human endothelial cells, and human adipocytes, and the tumor tissue is human breast tumor.
8. A three-dimensional, engineered, biological tumor model comprising:
a. stromal tissue; and
b. tumor tissue;
the tumor tissue comprising cancer cells, the tumor tissue in contact with the stromal tissue to form the three-dimensional, engineered, biological tumor model, wherein the tumor model does not comprise a perfusable vascular network, does not comprise red blood cells, and lacks innervation and neural tissue;
provided that the stromal tissue was bioprinted from a stromal bio-ink comprising human preadipocytes exposed to an adipocyte differentiation media for preadipocytes, and the tumor tissue was bioprinted from a tumor bio-ink;
provided that the stromal bio-ink and the tumor bio-ink each comprise a reversibly cross-linkable extrusion compound utilized to physically stabilize the tumor model architecture prior to cohesion of the cells.
9. The tumor model of claim 8 , wherein the tumor tissue is surrounded on three or more sides by the stromal tissue to form the three-dimensional, engineered, biological tumor model.
10. The tumor model of claim 9 , wherein the tumor tissue is completely surrounded on all sides by the stromal tissue to form the three-dimensional, engineered, biological tumor model.
11. The tumor model of claim 8 , wherein the model is substantially free of pre-formed scaffold.
12. The tumor model of claim 8 , wherein the stromal tissue comprises:
a. endothelial cells,
b. fibroblasts, and
c. adipocytes or preadipocytes or both adipocytes and preadipocytes.
13. The tumor model of claim 8 , wherein the tumor tissue further comprises one or more of: endothelial cells, fibroblasts, adipocytes, and preadipocytes.
14. The tumor model of claim 8 , wherein the tumor model is a human breast cancer model, the stromal tissue is human breast stroma comprising human mammary fibroblasts, human endothelial cells, and human adipocytes, and the tumor tissue is human breast tumor.
15. An array of three-dimensional, engineered, biological tumor models, each tumor model comprising: stromal tissue and tumor tissue; the tumor tissue comprising cancer cells, the tumor tissue in contact with the stromal tissue to form each three-dimensional, engineered, biological tumor model, wherein the tumor model does not comprise a perfusable vascular network, does not comprise red blood cells, and lacks innervation and neural tissue; provided that the stromal tissue was bioprinted from a stromal bio-ink comprising human preadipocytes exposed to an adipocyte differentiation media for preadipocytes; provided that the array is adapted for use in a high throughput assay.
16. The array of claim 15 , wherein the tumor tissue is surrounded on three or more sides by the stromal tissue to form each three-dimensional, engineered, biological tumor model.
17. The array of claim 16 , wherein the tumor tissue is completely surrounded on all sides by the stromal tissue to form each three-dimensional, engineered, biological tumor model.
18. The array of claim 15 , wherein each tumor model is substantially free of pre-formed scaffold.
19. The array of claim 15 , wherein each tumor model is in a well of a multi-well plate.
20. The array of claim 15 , wherein the stromal tissue comprises: endothelial cells, fibroblasts, and adipocytes or preadipocytes or both adipocytes and preadipocytes.
21. The array of claim 15 , wherein the tumor tissue further comprises one or more of: endothelial cells, fibroblasts, adipocytes, and preadipocytes.
22. The array of claim 15 , wherein each tumor model is a human breast cancer model, the stromal tissue is human breast stroma comprising human mammary fibroblasts, human endothelial cells, and human adipocytes, and the tumor tissue is human breast tumor.
23. An array of three-dimensional, engineered, biological tumor models, each tumor model comprising: stromal tissue and tumor tissue; the tumor tissue comprising cancer cells, the tumor tissue in contact with the stromal tissue to form each three-dimensional, engineered, biological tumor model, wherein the tumor model does not comprise a perfusable vascular network, does not comprise red blood cells, and lacks innervation and neural tissue; provided that the stromal tissue was bioprinted from a stromal bio-ink comprising a reversibly crosslinkable extrusion compound and human preadipocytes exposed to an adipocyte differentiation media for preadipocytes, and the tumor tissue was bioprinted from a tumor bio-ink comprising a reversibly crosslinkable extrusion compound; provided that the array is adapted for use in a high throughput assay.
24. The array of claim 23 , wherein the tumor tissue is surrounded on three or more sides by the stromal tissue to form each three-dimensional, engineered, biological tumor model.
25. The array of claim 24 , wherein the tumor tissue is completely surrounded on all sides by the stromal tissue to form each three-dimensional, engineered, biological tumor model.
26. The array of claim 23 , wherein each tumor model is substantially free of pre-formed scaffold.
27. The array of claim 23 , wherein each tumor model is in a well of a multi-well plate.
28. The array of claim 23 , wherein the stromal tissue comprises: endothelial cells, fibroblasts, and adipocytes, preadipocytes, or both adipocytes and preadipocytes.
29. The array of claim 23 , wherein the tumor tissue further comprises one or more of: endothelial cells, fibroblasts, and adipocytes, preadipocytes, or both adipocytes and preadipocytes.
30. The array of claim 23 , wherein each tumor model is a human breast cancer model, the stromal tissue is human breast stroma comprising human mammary fibroblasts, human endothelial cells, and human adipocytes, and the tumor tissue is human breast tumor.